Filmed at the 2016 EACTS Annual Meeting in Barcelona, Spain, Leanne Harling of Imperial College in London, UK, moderates a discussion on the role of surgical therapy for N2 lung cancer. Doug Mathisen of Massachusettes General Hospital in Boston, Massachusetts, and Erino Rendina of the University La Sapienza in Rome, Italy, share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.
Surgery for Stage IIIa N2 Disease
Citation
Mathisen, Douglas; Rendina, Erino; Harling, Leanne (2017): Surgery for Stage IIIa N2 Disease.
CTSNet, Inc. https://doi.org/10.25373/ctsnet.5588737
Retrieved: 20:35, Nov 13, 2017 (GMT)
Reach and Traffic
1,238 views
16 views
Related Content
Cancer
RATS Left Lower Lobectomy for T4 NSCLC After Immunotherapy
By Benjamin Bottet et al.
Dec. 20, 2023
Cancer
Use of the Sonicision Cordless Energy Device for Lung Resection
By George Whittaker et al.
Dec. 13, 2023
Cancer
Right Lower Superior Segmentectomy Using ArtiSental Bipolar Precise Dissector
By Teruya Komatsu et al.
Nov. 30, 2023
GREAT DISCUSSION. WHAT ABOUT ABSOLUTE VISUAL CLEARANCE OF ALL N2 nodes. I think it’s got a role along with adjuvant Chemo n Radiotherapy